series-c-plus
Stage
2016
Founded
4
Investors
About
OMass Therapeutics is a biotechnology company developing small-molecule therapeutics using a proprietary discovery platform that leverages mass-spectrometry-enabled approaches to identify and optimize ligands for challenging protein targets.
Explore OMass Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.